ERBB2 and breast cancer: There are three main subtypes of breast cancer: ER/PR-overexpressing breast cancer (accounting for approximately 60% of cases), HER2-overexpressing breast cancer (approximately 20%), and triple-negative breast cancer (TNBC) (approximately 20%) (3).